foscarnet has been researched along with Lymphoma, AIDS-Related in 6 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Lymphoma, AIDS-Related: B-cell lymphoid tumors that occur in association with AIDS. Patients often present with an advanced stage of disease and highly malignant subtypes including BURKITT LYMPHOMA; IMMUNOBLASTIC LARGE-CELL LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; and DIFFUSE, LARGE B-CELL, LYMPHOMA. The tumors are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in AIDS is a complex result of EBV infection, HIV antigenic stimulation, and T-cell-dependent HIV activation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The lymphoproliferative disorders are usually treated with a combination of cytotoxic drugs, and virustatic medication is thought to be ineffective." | 5.31 | Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet. ( Delecluse, HJ; Huhn, D; Ruhnke, M; Schneider, U; Stein, H, 2000) |
| " Long-term administration (>1 year) of high-dose acyclovir or similar agents with anti-EBV activity may prevent NHL in patients with AIDS." | 1.31 | Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: case-control and historical cohort studies. ( Fong, IW; Fong, MW; Ho, J; Lo, B; Toy, C, 2000) |
| "The lymphoproliferative disorders are usually treated with a combination of cytotoxic drugs, and virustatic medication is thought to be ineffective." | 1.31 | Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet. ( Delecluse, HJ; Huhn, D; Ruhnke, M; Schneider, U; Stein, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ridha, E | 1 |
| Cookson, H | 1 |
| Devitt, E | 1 |
| Nelson, M | 1 |
| Marretta, L | 1 |
| Stocker, H | 1 |
| Drauz, D | 1 |
| Mueller, M | 1 |
| Masuhr, A | 1 |
| Dieckmann, S | 1 |
| Wong, V | 1 |
| Koch, A | 1 |
| Grueneisen, A | 1 |
| Arastéh, K | 1 |
| Weiss, R | 1 |
| Rabkin, CS | 1 |
| Testa, MA | 1 |
| Huang, J | 1 |
| Von Roenn, JH | 1 |
| Fong, IW | 1 |
| Ho, J | 1 |
| Toy, C | 1 |
| Lo, B | 1 |
| Fong, MW | 1 |
| Schneider, U | 1 |
| Ruhnke, M | 1 |
| Delecluse, HJ | 1 |
| Stein, H | 1 |
| Huhn, D | 1 |
6 other studies available for foscarnet and Lymphoma, AIDS-Related
| Article | Year |
|---|---|
Febrile neutropenia in a HIV positive individual post-chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytomegalovirus | 2010 |
Treatment of HIV-related primary central nervous system lymphoma with AZT high dose, HAART, interleukin-2 and foscarnet in three patients.
Topics: Adult; Antiretroviral Therapy, Highly Active; Central Nervous System Neoplasms; Foscarnet; Humans; I | 2011 |
Anti-viral therapy for lymphoma.
Topics: Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Foscarnet; Humans; Lymphoma, AID | 2000 |
Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; | 1999 |
Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: case-control and historical cohort studies.
Topics: Acyclovir; Adult; Antiviral Agents; Case-Control Studies; Cohort Studies; Drug Therapy, Combination; | 2000 |
Regression of Epstein-Barr virus-associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Epstein-Barr Virus Infections; Foscarne | 2000 |